" /> Obrixtamig - CISMeF





Preferred Label : Obrixtamig;

NCIt synonyms : DLL3/CD3 Bispecific Antibody BI 764532; T-cell Engager BI 764532; Anti-DLL3/CD3 Bispecific Antibody BI 764532;

NCIt definition : A bispecific T-cell engager antibody directed against both the tumor-associated antigen (TAA) delta-like protein 3 (DLL3) and the CD3 antigen found on T-lymphocytes, with potential immunostimulating and antineoplastic activities. Upon administration, obrixtamig binds to both the CD3 antigen on cytotoxic T-lymphocytes (CTLs) and the DLL3 antigen on DLL3-expressing tumor cells. This activates and redirects CTLs to DLL3-expressing tumor cells, which results in the CTL-mediated cell death of DLL3-expressing tumor cells. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.;

UNII : Y09G7LIC1A;

CAS number : 2851943-09-2;

Molecule name : BI-764532; BI 764532;

NCI Metathesaurus CUI : CL1647547;

Details


You can consult :


Nous contacter.
09/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.